PreMarket Price
PreMarket Price
Centene Corporation (CNC) logo

Stock Analysis

Centene CorporationCNC

Price:$69.16Market Closed-1.91%at last close

Sector: Financial Services · Industry: Hospital & Medical Service Plans

AnalystsHold27 analysts
EW Score 39/65 · #124Mkt Cap 34.28BROE -22.5%
Low $31.80$69.16High $70.51

Price is 97% of the way from the year's low to its high.

Cash $24.15BNet cash $8.05BDebt $16.11B

Cash covers 150% of debt · Q2 2026.

Profilev70g20p0h65q65m48

PMP Verdict

Cheap for a reason — weak fundamentals

Strengths

  • Financial Health65
  • Quality65

Risks

  • Profitability0
  • Growth20
Revenue +11.5% CAGRP/S 24th percentile

Cheap for a reason — fundamentals remain weak.

Bull Case

  • ✓Revenue CAGR 11.5% — durable top-line growth

What's happening with CNC

Last big move: +4.0% on 2026-10-02

Profile

Valuation — 70/100 (Moderate) P/E vs own history: n/a → 10/25 FCF yield: 26.1% → 25/25 P/S: 0.2x → 25/25 EV/EBIT: n/a → 10/25Valuation70Growth — 20/100 (Weak) Revenue CAGR: 11.5% → 20/25 Net income CAGR: n/a → 0/25 EPS CAGR 5Y: n/a → 0/25 Fwd implied growth: n/a → 0/25Growth20Profitability — 0/100 (Weak) ROIC: -30.5% → 0/25 ROE: -22.5% → 0/25 Net margin: -2.5% → 0/25 Operating margin: -2.8% → 0/25Profitability0Financial Health — 65/100 (Moderate) Altman Z: 1.56 → 10/25 Current ratio: 1.12 → 12/25 Interest coverage: 6.2x → 18/25 Net cash / debt: Net cash → 25/25Health65Quality — 65/100 (Moderate) Piotroski F: 6/9 → 15/25 Beneish M: -3.19 → 25/25 FCF conversion: -176% → 0/25 Margin stability: σ 1.4% → 25/25Quality65Moat — 48/100 (Weak) ROIC >12% years: 2/10 yrs → 0/25 Median gross margin: 96.4% → 25/25 FCF-positive years: 9/10 yrs → 18/25 Worst-year net margin: worst -3.4% → 5/25Moat48

profitability, growth and moat lag behind.

How is each axis scored?
  • Valuation70/100 · Moderate
    • P/E vs own history (n/a)10/25
    • FCF yield (26.1%)25/25
    • P/S (0.2x)25/25
    • EV/EBIT (n/a)10/25
  • Growth20/100 · Weak
    • Revenue CAGR (11.5%)20/25
    • Net income CAGR (n/a)0/25
    • EPS CAGR 5Y (n/a)0/25
    • Fwd implied growth (n/a)0/25
  • Profitability0/100 · Weak
    • ROIC (-30.5%)0/25
    • ROE (-22.5%)0/25
    • Net margin (-2.5%)0/25
    • Operating margin (-2.8%)0/25
  • Financial Health65/100 · Moderate
    • Altman Z (1.56)10/25
    • Current ratio (1.12)12/25
    • Interest coverage (6.2x)18/25
    • Net cash / debt (Net cash)25/25
  • Quality65/100 · Moderate
    • Piotroski F (6/9)15/25
    • Beneish M (-3.19)25/25
    • FCF conversion (-176%)0/25
    • Margin stability (σ 1.4%)25/25
  • Moat48/100 · Weak
    • ROIC >12% years (2/10 yrs)0/25
    • Median gross margin (96.4%)25/25
    • FCF-positive years (9/10 yrs)18/25
    • Worst-year net margin (worst -3.4%)5/25

Risk Flags

  • ⚠Altman Z 1.6 — distress-zone balance sheet

About Centene Corporation

Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Show more

Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.

Headquarters: ST LOUIS, MO · Employees: 61,100 · Website ↗

Price History

Weekly Candlestick Chart — up to 5Y

Key Metrics

Financial snapshot · Tap any metric for its definition and grade

TTM Snapshot

trailing twelve months · YoY
Revenue
202.9B+14%
Op. Income
-5.6B-394%
Net Income
-5.1B-348%
EPS
-10.3-348%
Operating CF
9.7B+464%
Free CF
9B+729%

Valuation

70B+
P/E (TTM)—

Price / TTM EPS (own statements)

P/FCF4.0xA

Grade A: CheapPrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative

FCF Yield26.1%A

Grade A: ValueTTM (OCF − CapEx) / Market Cap — vs own 5Y history: 0.6%–43.8% · 92nd pct

P/S (TTM)0.17xA

Grade A: CheapPrice / TTM Revenue (own statements) — vs own 5Y history: 0.1x–0.4x · 24th pct

EV/EBITDA8.5xA

Grade A: CheapEnterprise value / EBITDA (Finnhub) — capital-structure neutral

EV/Sales0.1xA

Grade A: CheapEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple

Forward P/E14.2xA

Grade A: CheapPrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth

P/B Ratio1.51xA

Grade A: FairPrice to Book Value. Neg. equity = heavy buybacks

PEG Ratio—

Finnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)

Dividend Yield—

TTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress

Payout Ratio—

Dividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable

Profitability

0E
ROIC-30.5%D

Grade D: LowNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat

ROE-22.5%D

Grade D: WeakReturn on Equity. Neg. equity = heavy buybacks

ROA-6.3%D

Grade D: WeakReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit

Net Margin-2.5%D

Grade D: LowNet Income / Revenue

Operating Margin-2.8%D

Grade D: LowTTM EBIT / TTM Revenue

Gross Margin98.6%A

Grade A: PremiumGross Profit / Revenue

FCF Margin4.4%D

Grade D: LowFCF / Revenue

True FCF Margin4.3%D

Grade D: LowTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost

Growth

20E
Revenue CAGR11.5%C

Grade C: OkCompound annual revenue growth (up to 5Y depending on data availability)

Net Income CAGR—

Compound annual net income growth (up to 5Y depending on data availability)

EPS CAGR (5Y)—

Compound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0

Implied EPS Growth—

Analyst forward EPS (normalized basis) vs our GAAP TTM EPS — different bases, so extreme values usually mark cyclically depressed TTM earnings, not real growth

Dilution (5Y)-16.2%A

Grade A: BuybacksShare count change over 5Y

SBC / Net Income—

Stock-based comp/Net income. >30% = dilution risk

SBC / Revenue0.1%A

Grade A: LowTTM stock-based comp / TTM Revenue

Financial Health

65B
Altman Z-Score1.56D

Grade D: DistressBankruptcy risk. >3 Safe, <1.8 Distress

Current Ratio1.12xC

Grade C: OkCurrent Assets/Liabilities

Quick Ratio1.12xA

Grade A: High(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory

Interest Coverage6.2xC

Grade C: OkEBIT/Interest. >10 Strong

Debt RepaymentNet CashA

Grade A: FastYears to repay net debt via FCF

Net Debt/EBIT1.4xA

Grade A: LowLeverage. <2x Low, >4x High

Debt/Equity0.71xA

Grade A: LowDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.

Cash / Debt1.50xA

Grade A: CoveredCash covers how much of total debt. >1 = could repay all debt from cash

Quality

65B
Piotroski F-Score6/9C

Grade C: AverageFinancial strength 0–9. >7 Strong

Beneish M-Score-3.19A

Grade A: SafeEarnings manipulation risk. < -2.22 Safe

FCF Conversion-175.5%D

Grade D: PoorFCF / Net Income

Margin Stability1.4%A

Grade A: StableEBIT margin std deviation. Lower = stable

Capex / Revenue0.4%A

Grade A: Asset-lightTTM CapEx / TTM Revenue — high % = capital-hungry business

Asset Turnover2.43xA

Grade A: HighRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales

1/10 Loss Years

Insider Transactions

SEC Form 4 · 8 records
Open-market · 90dBuy —Sell $6.9M (2)Other filings 3Net open-market selling

P/S codes are the directional signal; grants, option exercises and tax withholding carry none. Form 4 doesn't flag 10b5-1 plans — scheduled sales may appear within open-market sells.

Recent insider transactions
Trade dateTransactionShares
Carson Michael A
Filed
Tax withholding
-7130
PIENKOS THEODORE J
Filed
Tax withholding
-1092
KOSTER CHRISTOPHER
Filed
SellOpen market sale
-56500
KOSTER CHRISTOPHER
Filed
SellOpen market sale
-47603
DIAZ PAUL J
Filed
Grant / award
+2.8K
Show 3 more filings
Additional recent insider transactions
Trade dateTransactionShares
Tyler Lauren M
Filed
Grant / award
+3.2K
Tyler Lauren M
Filed
Grant / award
+61
TANJI KENNETH
Filed
Grant / award
+581
More metrics — Moat, Per Share, Balance Sheet, Market

Moat

48D+
ROIC >12% Years2/10 yrsD

Grade D: WeakShare of completed fiscal years with ROIC > 12% — measures multi-year capital-return durability

Gross Margin (Med.)96.4%A

Grade A: DurableMedian annual gross margin across available fiscal years — pricing-power durability

FCF-Positive Years9/10 yrsA

Grade A: DurableShare of completed fiscal years with positive free cash flow

Net Margin Floor-3.4%D

Grade D: WeakWeakest annual net margin across completed fiscal years — recession/downcycle resilience

Per Share

EPS (TTM)—

TTM net income per share (Finnhub fallback)

Cash / Share$48.08

Cash & short-term investments per share (Finnhub)

Book Value / Share$45.67

Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks

Balance Sheet

Total Debt$16.11B

Total debt obligations (short + long term)

Cash & Equiv.$24.15B

Cash and short-term investments

Net Debt$-8.05BA

Grade A: Net CashTotal Debt minus Cash. Negative = Net Cash position

Total Equity$22.66B

Shareholders' equity (book value)

Asset / Liability—

Total Assets / Total Liabilities

Market

Market Cap$34.28B

Current Market Capitalization

Beta1.09B

Grade B: MarketPrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings

How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.

Financials as of Jun 2026 · Ratio snapshot Oct 17, 2026

Key Insights: Centene Corporation (CNC)

CNC is down 1.91% at the last close. Piotroski F-Score of 6/9 indicates mixed fundamentals for Centene Corporation. Altman Z-Score of 1.56 is below the 1.81 distress threshold — an elevated financial-risk flag. Beneish M-Score of -3.19 suggests a low likelihood of earnings manipulation.

  • Company is effectively debt-free after netting cash.
  • Centene Corporation posted a net loss in 1 of 10 available completed fiscal years (2016–2025).
  • At a valuation score of 70/100, CNC trades near the cheapest end of its own historical range.

See how CNC ranks on the Capex Tracker — top 50 capital spenders compared.

Recent Market Moves

See all CNC moves →
DateSessionPriceMoveZ-Score
Oct 2After-hours63.40+3.95%2.20

Frequently Asked Questions about CNC

What is the current Centene Corporation (CNC) stock price?

CNC is trading at $69.16 at the last market close, down 1.91% on the session. PreMarketPrice tracks CNC pre-market, intraday and after-hours prices.

Is CNC stock a buy right now?

PreMarketPrice's quantitative model rates Centene Corporation's financial health at 65/100. This is a data-driven snapshot of fundamentals, not investment advice.

Is CNC stock overvalued?

Centene Corporation trades at a trailing P/E of n/a and our valuation score rates it 70/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.

When does Centene Corporation report earnings?

No confirmed earnings date is currently scheduled for CNC. The Earnings section lists recent reports and updates as dates are announced.

What sector does Centene Corporation operate in?

Centene Corporation operates in the Financial Services sector, within the Hospital & Medical Service Plans industry. The Related Stocks section lists sector peers for comparison.

What does Centene Corporation do?

Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges.

About Centene Corporation (CNC) Stock

Centene Corporation (CNC) is a US-listed stock operating in the Financial Services sector, specifically the Hospital & Medical Service Plans industry. As of the latest update, Centene Corporation is trading at $69.16, down 1.91% on the day with a market capitalization of $34.3 billion. The financial health score for CNC is 65/100, which indicates good financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for CNC stock.

CNC Stock Analysis & Key Metrics

On PreMarketPrice, you can track Centene Corporation (CNC) across multiple dimensions:

Is CNC a Good Stock to Buy?

This page provides data-driven analysis to help you evaluate Centene Corporation (CNC) as an investment. The financial health score of 65/100 suggests good financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.

Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Centene Corporation (CNC) trades on NYSE. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.

Related opportunities

Moving today in Financial Services
More Hospital & Medical Service Plans stocks
Cheaper alternatives
Similar fundamentals